Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance.

Authors :: Hassoun H
Roshal M
Sabari J
Nguyen J
Gao Q
Devlin SM
Landau H
Lendvai N
Chung DJ
Lesokhin AM
Korde N
Mailankody S
Dogan A
Giralt SA
Landgren CO
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2017 Dec; Vol. 58 (12), pp. 2962-2965. Date of Electronic Publication: 2017 May 09.
Publication Year :: 2017

Subjects :: Antineoplastic Combined Chemotherapy Protocols adverse effects
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Biomarkers
Hematopoietic Stem Cell Transplantation adverse effects
Hematopoietic Stem Cell Transplantation methods
Humans
Lenalidomide
Multiple Myeloma therapy
Thalidomide adverse effects
Thalidomide therapeutic use
Immunophenotyping
Leukemoid Reaction diagnosis
Leukemoid Reaction etiology
Multiple Myeloma complications
Plasma Cells pathology
Thalidomide analogs & derivatives

Full Text Access

Tools